Literature DB >> 10353057

Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis.

D C Apakama1, A Bleetman.   

Abstract

The case of a 6 year old child who presented with convulsions and coma after unsupervised self administration of intranasal desmopressin (DDAVP) for nocturnal enuresis is presented. Children with enuresis can be embarassed by their condition and may believe that multiple doses of their nasal spray may bring about a rapid resolution. Water intoxication is an uncommon but serious adverse effect of treatment with intranasal DDAVP. These patients may present with seizure, mental state changes, or both. Basic management consists of stopping the drug, fluid restriction, and suppressive treatment for seizures. Recovery is usually rapid and complete. Administration of the nasal spray in children should be supervised by parents to prevent highly motivated children from accidental overdose. The risks of high fluid intake need to be carefully explained to both parents and children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353057      PMCID: PMC1343345          DOI: 10.1136/emj.16.3.229

Source DB:  PubMed          Journal:  J Accid Emerg Med        ISSN: 1351-0622


  8 in total

Review 1.  Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

Authors:  W L Robson; J P Nørgaard; A K Leung
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

2.  Hyponatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing.

Authors:  M Schwab; H Ruder
Journal:  Eur J Pediatr       Date:  1997-08       Impact factor: 3.183

3.  Convulsion and coma after intranasal desmopressin in cystic fibrosis.

Authors:  E J Simmonds; M J Mahony; J M Little
Journal:  BMJ       Date:  1988-12-17

4.  Hyponatraemic convulsion associated with desmopressin and imipramine treatment.

Authors:  M Hamed; H Mitchell; D J Clow
Journal:  BMJ       Date:  1993-05-01

5.  Hyponatraemia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna.

Authors:  M Schwab; D Wenzel; H Ruder
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

Review 6.  Intranasal desmopressin-induced hyponatremia.

Authors:  S L Williford; S A Bernstein
Journal:  Pharmacotherapy       Date:  1996 Jan-Feb       Impact factor: 4.705

7.  Hyponatremic seizure in a child using desmopressin for nocturnal enuresis.

Authors:  M B Donoghue; M E Latimer; H L Pillsbury; J H Hertzog
Journal:  Arch Pediatr Adolesc Med       Date:  1998-03

Review 8.  Desmopressin.

Authors:  D W Richardson; A G Robinson
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

  8 in total
  3 in total

Review 1.  Modern approach in treatment of diabetes insipidus.

Authors:  Elvedina Kapić; Fahir Becić; Maida Todić
Journal:  Bosn J Basic Med Sci       Date:  2005-05       Impact factor: 3.363

2.  Comparing alarms, desmopressin, and combined treatment in Chinese enuretic children.

Authors:  Cherry Fai-Ngo Ng; Sik-Nin Wong
Journal:  Pediatr Nephrol       Date:  2004-12-17       Impact factor: 3.714

Review 3.  Comparative tolerability of drug treatment for nocturnal enuresis in children.

Authors:  Dominik Müller; Charles C Roehr; Paul Eggert
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.